Characterization of a High-affinity Galanin Receptor in the Rat Anterior Pituitary: Absence of Biological Effect and Reduced Membrane Binding of the Antagonist M15 Differentiate It from the Brain/gut Receptor
Overview
Affiliations
Structure-activity studies demonstrate that galanin fragments 1-15 and 2-29 are fully active, whereas fragment 3-29 has been reported to be inactive, in a number of different in vivo models. M15, a chimeric peptide comprising galanin 1-13 and substance P5-11, has recently been found to be a potent galanin antagonist. Direct effects of galanin at the level of the pituitary have been defined, yet, paradoxically, a number of studies have been unable to demonstrate galanin binding to an anterior pituitary receptor. Porcine galanin stimulated prolactin release from dispersed rat anterior pituitary cells up to 180% +/- 12% (mean +/- SEM) of control secretion. The addition of a specific galanin antiserum caused a profound inhibition of basal prolactin release, maximal inhibition being 12% +/- 0.5% of control secretion. Addition of M15 produced no effect on basal or galanin-stimulated prolactin release. Galanin fragment 3-29 was fully active when compared to galanin 1-29. Fragments 5-29 and 8-29 stimulated prolactin release to a lesser extent and galanin 1-15, 10-29, and 20-29 had no significant prolactin-releasing activity. Using [mono(125I)iodo-Tyr26]galanin or porcine 125I-labeled Bolton-Hunter [mono(125I)iodo-Lys25]galanin, no anterior pituitary membrane binding was observed. In contrast, 125I-labeled Bolton-Hunter N-terminally labeled galanin allowed characterization of a single high-affinity anterior pituitary galanin receptor with a Kd of 4.4 +/- 0.34 nM and a Bmax of 79 +/- 8.3 fmol/mg of protein. The IC50 for porcine galanin was 0.51 +/- 0.04 nM but for M15 was in excess of 10 microM. Galanin 3-29 fully displaced the label with an IC50 of 0.96 +/- 0.7 nM. The IC50 for galanin 5-29 was 200 nM, whereas 8-29 and 1-15 were > 1 microM. Galanin 10-29 and 20-29 failed to displace the label. These data suggest the presence of a high-affinity pituitary galanin receptor, designated GAL-R2, in which region 3-10 and amino acid 25 are crucial for membrane binding and biological activity, in contrast to the known gut/brain galanin receptor (designated GAL-R1). A number of tissues known to bind or respond to galanin were screened. GAL-R2 would appear to be expressed only in the anterior pituitary and hypothalamus.
Petrescu A, Grant S, Williams E, Frampton G, Parks N, Blaney H Am J Pathol. 2020; 190(3):586-601.
PMID: 31953035 PMC: 7074378. DOI: 10.1016/j.ajpath.2019.10.023.
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.
Alexander S, Benson H, Faccenda E, Pawson A, Sharman J, Spedding M Br J Pharmacol. 2014; 170(8):1459-581.
PMID: 24517644 PMC: 3892287. DOI: 10.1111/bph.12445.
Alarin stimulates food intake and gonadotrophin release in male rats.
Boughton C, Patterson M, Bewick G, Tadross J, Gardiner J, Beale K Br J Pharmacol. 2010; 161(3):601-13.
PMID: 20880399 PMC: 2990158. DOI: 10.1111/j.1476-5381.2010.00893.x.
Stimulation of anterior pituitary galanin and prolactin gene expression in suckling rats.
Ren J, Koenig J, Hooi S Endocrine. 2000; 11(3):251-6.
PMID: 10786821 DOI: 10.1385/ENDO:11:3:251.
Spady T, McComb R, Shull J Endocrine. 2000; 11(3):217-33.
PMID: 10786818 DOI: 10.1385/ENDO:11:3:217.